Clinical Trial Update: Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating personalized transdermal nicotine replacement for tobacco use disorder reports on efficacy and neural correlates. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Tobacco Use Disorder, Nicotine Dependence | Phase 2, Phase 3 | Status: TERMINATED